U.K.-based biopharmaceutical giant AstraZeneca partnered with BCD Travel to bring 70 countries under global travel program management in just seven months. A case study explains how consolidation enabled innovations and improvements that led to results.
The company saved 15% on managed travel spend in one year. It gained data-centered, actionable insights into 95% of its managed travel spend. And the improved program performance helped the company achieve 86% traveler satisfaction.
“We needed comprehensive, consolidated data to understand where out-of-policy spend was happening and then make improvements,” said Kerrie Henshaw-Cox, AstraZeneca’s travel program leader. “Our consolidated travel program enables the travel team to better support AstraZeneca business leaders.”